Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
| Status: | Completed |
|---|---|
| Conditions: | Pulmonary, Hematology |
| Therapuetic Areas: | Hematology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any - 21 |
| Updated: | 4/2/2016 |
| Start Date: | July 2008 |
| End Date: | July 2011 |
| Contact: | Kimberly Boynton |
| Email: | boynton@stanford.edu |
| Phone: | (650) 498-6713 |
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure
The aim of our study is to determine whether a clinically relevant laboratory measurement
(of seven specific immunologic biochemicals in the blood) can identify which bone marrow
transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to
devise a comprehensive and inclusive laboratory test that is effective at determining who is
likely to go on to respiratory failure, in order to facilitate early medical intervention.
(of seven specific immunologic biochemicals in the blood) can identify which bone marrow
transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to
devise a comprehensive and inclusive laboratory test that is effective at determining who is
likely to go on to respiratory failure, in order to facilitate early medical intervention.
Inclusion Criteria:- Hematopoietic stem cell transplantation (HSCT) for any indication.
- Patients will range from age 0 to age 21. There is no gender restriction. We expect
the male to female ratio to end up being about 50/50
- Ability to understand and the willingness to sign a written informed consent
document.
We found this trial at
1
site
Stanford University School of Medicine Vast in both its physical scale and its impact on...
Click here to add this to my saved trials
